GT200100015A - Eteres de dicarboxilato de calcio, metodos para su preparacion y tratamiento de las enfermedades vasculares y diabetescon los mismos. - Google Patents
Eteres de dicarboxilato de calcio, metodos para su preparacion y tratamiento de las enfermedades vasculares y diabetescon los mismos.Info
- Publication number
- GT200100015A GT200100015A GT200100015A GT200100015A GT200100015A GT 200100015 A GT200100015 A GT 200100015A GT 200100015 A GT200100015 A GT 200100015A GT 200100015 A GT200100015 A GT 200100015A GT 200100015 A GT200100015 A GT 200100015A
- Authority
- GT
- Guatemala
- Prior art keywords
- methods
- treatment
- solvatos
- same
- diabetescon
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/125—Saturated compounds having only one carboxyl group and containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/305—Saturated compounds containing more than one carboxyl group containing ether groups, groups, groups, or groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A LA SAL DE MONOCALCIO DEL ACIDO 6(5CARBOXI5METILHEXILOXI)2,2,DIMELHEXANOICO (1:1) Y A SUS SOLVATOS, A LOS METODOS PARA PRODUCIR LA SAL EN FORMA CRISTALINA, A METODOS PARA PRODUCIR SOLVATOS DE ALCOHOL DE LA SAL DE MONOCALCIO EN FORMA CRISTALINA, Y AL TRATAMIENTO DE LAS ENFERMEDADES CON LOS MISMOS. EN PARTICULAR LOS COMPUESTOS MENCIONADOS SON UTILES PARA REDUCIR CIERTOS LIPIDOS PLASMATICOS EN ANIMALES INCLUYENDO LA LP(A), TRIGLICERIDOS, VLDLCOLESTEROL, Y LDLCOLESTEROL, ASI COMO PARA ELEVAR EL HDLCOLESTEROL. LOS COMPUESTOS SON UTILES TAMBIEN PARA TRATAR LA DIABETES MELLITUS.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17782300P | 2000-01-25 | 2000-01-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GT200100015A true GT200100015A (es) | 2001-10-19 |
Family
ID=22650106
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GT200100015A GT200100015A (es) | 2000-01-25 | 2001-01-23 | Eteres de dicarboxilato de calcio, metodos para su preparacion y tratamiento de las enfermedades vasculares y diabetescon los mismos. |
Country Status (39)
| Country | Link |
|---|---|
| EP (1) | EP1259474B1 (es) |
| JP (1) | JP4750995B2 (es) |
| KR (1) | KR20020073182A (es) |
| CN (1) | CN1395555A (es) |
| AP (1) | AP2002002587A0 (es) |
| AR (1) | AR029436A1 (es) |
| AT (1) | ATE431326T1 (es) |
| AU (1) | AU2214001A (es) |
| BG (1) | BG106851A (es) |
| BR (1) | BR0107763A (es) |
| CA (1) | CA2397960C (es) |
| CO (1) | CO5261537A1 (es) |
| CZ (1) | CZ20022474A3 (es) |
| DE (1) | DE60138686D1 (es) |
| DK (1) | DK1259474T3 (es) |
| DZ (1) | DZ3239A1 (es) |
| EA (1) | EA004862B1 (es) |
| EE (1) | EE200200404A (es) |
| ES (1) | ES2324281T3 (es) |
| GE (1) | GEP20053428B (es) |
| GT (1) | GT200100015A (es) |
| HN (1) | HN2001000011A (es) |
| HU (1) | HUP0204422A3 (es) |
| IL (1) | IL150541A0 (es) |
| IS (1) | IS6442A (es) |
| MA (1) | MA26867A1 (es) |
| MX (1) | MXPA02007223A (es) |
| NO (1) | NO20023526L (es) |
| NZ (1) | NZ519550A (es) |
| OA (1) | OA12166A (es) |
| PA (1) | PA8510601A1 (es) |
| PE (1) | PE20011064A1 (es) |
| PL (1) | PL357076A1 (es) |
| SK (1) | SK10622002A3 (es) |
| SV (1) | SV2002000290A (es) |
| TN (1) | TNSN01013A1 (es) |
| UY (1) | UY26550A1 (es) |
| WO (1) | WO2001055078A1 (es) |
| ZA (1) | ZA200205880B (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1481962A1 (en) * | 1997-12-12 | 2004-12-01 | Warner-Lambert Company LLC | New cholesterolemia-lowering carboxyalkylether compound |
| EP1539127A1 (en) * | 2002-08-22 | 2005-06-15 | Warner-Lambert Company Llc | Method of treating osteoarthritis |
| WO2006115130A1 (ja) * | 2005-04-19 | 2006-11-02 | Eisai R & D Management Co., Ltd. | ビス［（２ｓ）－３－［３－［（２ｓ）－３－（４－クロロ－２－シアノフェノキシ）－２－フルオロプロポキシ］フェニル］－２－イソプロポキシプロピオン酸］カルシウム及びその中間体 |
| US7816405B2 (en) | 2005-04-19 | 2010-10-19 | Eisai R&D Management Co., Ltd. | Calcium bis [(2S)-3-[3-[(2S)-3-(4-chloro-2-cyanophenoxy)-2-fluoropropoxy]phenyl ]-2-isopropoxypropionate] and intermediate thereof |
| CN111704543A (zh) * | 2014-11-14 | 2020-09-25 | 燿石治疗公司 | 用于制备α,ω-二羧酸封端的二烷醚的方法和中间体 |
| CN110996928A (zh) * | 2017-04-18 | 2020-04-10 | 燿石治疗公司 | 吉卡宾、其药学上可接受的盐、其组合物和其使用方法 |
| CN113396138A (zh) * | 2018-10-18 | 2021-09-14 | 燿石治疗公司 | 吉卡宾、其药学上可接受的盐、其组合物和其使用方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5648387A (en) * | 1995-03-24 | 1997-07-15 | Warner-Lambert Company | Carboxyalkylethers, formulations, and treatment of vascular diseases |
| NZ503982A (en) | 1997-12-12 | 2002-03-28 | Warner Lambert Co | Statin-carboxyalkylether combinations useful for treating vascular disorders and diabetes mellitus |
-
2001
- 2001-01-11 EP EP01900037A patent/EP1259474B1/en not_active Expired - Lifetime
- 2001-01-11 JP JP2001555021A patent/JP4750995B2/ja not_active Expired - Fee Related
- 2001-01-11 EA EA200200641A patent/EA004862B1/ru not_active IP Right Cessation
- 2001-01-11 DK DK01900037T patent/DK1259474T3/da active
- 2001-01-11 PL PL01357076A patent/PL357076A1/xx not_active Application Discontinuation
- 2001-01-11 MX MXPA02007223A patent/MXPA02007223A/es active IP Right Grant
- 2001-01-11 BR BR0107763-5A patent/BR0107763A/pt not_active IP Right Cessation
- 2001-01-11 CN CN01804045A patent/CN1395555A/zh active Pending
- 2001-01-11 IL IL15054101A patent/IL150541A0/xx unknown
- 2001-01-11 AT AT01900037T patent/ATE431326T1/de not_active IP Right Cessation
- 2001-01-11 CZ CZ20022474A patent/CZ20022474A3/cs unknown
- 2001-01-11 NZ NZ519550A patent/NZ519550A/en unknown
- 2001-01-11 WO PCT/IB2001/000026 patent/WO2001055078A1/en not_active Application Discontinuation
- 2001-01-11 AP APAP/P/2002/002587A patent/AP2002002587A0/en unknown
- 2001-01-11 DE DE60138686T patent/DE60138686D1/de not_active Expired - Lifetime
- 2001-01-11 CA CA002397960A patent/CA2397960C/en not_active Expired - Lifetime
- 2001-01-11 EE EEP200200404A patent/EE200200404A/xx unknown
- 2001-01-11 HU HU0204422A patent/HUP0204422A3/hu unknown
- 2001-01-11 KR KR1020027009519A patent/KR20020073182A/ko not_active Application Discontinuation
- 2001-01-11 GE GE4872A patent/GEP20053428B/en unknown
- 2001-01-11 SK SK1062-2002A patent/SK10622002A3/sk not_active Application Discontinuation
- 2001-01-11 OA OA1200200226A patent/OA12166A/en unknown
- 2001-01-11 AU AU22140/01A patent/AU2214001A/en not_active Abandoned
- 2001-01-11 ES ES01900037T patent/ES2324281T3/es not_active Expired - Lifetime
- 2001-01-11 DZ DZ013239A patent/DZ3239A1/fr active
- 2001-01-22 SV SV2001000290A patent/SV2002000290A/es not_active Application Discontinuation
- 2001-01-22 UY UY26550A patent/UY26550A1/es not_active Application Discontinuation
- 2001-01-23 GT GT200100015A patent/GT200100015A/es unknown
- 2001-01-23 PA PA20018510601A patent/PA8510601A1/es unknown
- 2001-01-23 AR ARP010100284A patent/AR029436A1/es unknown
- 2001-01-24 HN HN2001000011A patent/HN2001000011A/es unknown
- 2001-01-24 CO CO01005267A patent/CO5261537A1/es not_active Application Discontinuation
- 2001-01-24 TN TNTNSN01013A patent/TNSN01013A1/fr unknown
- 2001-01-24 PE PE2001000076A patent/PE20011064A1/es not_active Application Discontinuation
-
2002
- 2002-06-20 BG BG106851A patent/BG106851A/xx unknown
- 2002-06-25 IS IS6442A patent/IS6442A/is unknown
- 2002-07-22 MA MA26735A patent/MA26867A1/fr unknown
- 2002-07-23 ZA ZA200205880A patent/ZA200205880B/xx unknown
- 2002-07-24 NO NO20023526A patent/NO20023526L/no not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200800303A1 (ru) | Применение производных и аналогов тиазола при нарушениях, вызванных свободными жирными кислотами | |
| EA200700860A1 (ru) | (бифенил)карбоновые кислоты и их производные | |
| DOP2005000251A (es) | 3-amino-pirazol [3,4b] piridinas como inhibidores de proteintirosinquinasas, su preparacion y uso como medicamento. | |
| GT200100134A (es) | Sales estables de acido o-acetilsalicilico con aminoacidos basicos | |
| GT200200272A (es) | Formas de sal e-2-metoxi-n-(3-{4-[3-metil-4-(6-metilpiridin-3-iloxi) fenilamino] quinazolin-6-il} alil)acetamidayprocedimiento para la produccion | |
| UY30098A1 (es) | Compuestos de tiazol y metodos de uso | |
| UY28280A1 (es) | 2- hidroxi - 3- diaminoalcanos de benzamida | |
| PE20070244A1 (es) | Biotejido de colageno derivado de placenta para el tratamiento de ulceras en la pierna | |
| PA8622401A1 (es) | Derivados de acido 7-fenilamino-4-quinolona-3-carboxilico,procesos para su preparacion y su uso como medicamentos | |
| GT200500107A (es) | Derivados de fenol y tiofenol 3-0 4-monosustituidos utiles como ligandos de h3 | |
| ECSP034848A (es) | Derivados oxazol acido carboxilico sustituidos para uso como activadores ppar-alpha y -gamma en el tratamiento de diabetes | |
| GT200500360A (es) | Compuestos organicos | |
| PA8604201A1 (es) | Derivados de 2-amino-piridina utiles para el tratamiento de enfermedades | |
| PA8627001A1 (es) | Compuestos para el tratamiento de enfermedades | |
| UY29343A1 (es) | Pirazolopiridinas y sales de las mismas, una composición farmacéutica que comprende dichos compuestos, un método para prepararlos y su uso. | |
| ECSP056017A (es) | Derivados del acido 3-(1-[3-(1,3-benzotiazol-6-il) propilcarbamoil] cicloalquil) propanoico como inhibidores de nep | |
| UY28702A1 (es) | Derivados de quinazolina | |
| GT200100015A (es) | Eteres de dicarboxilato de calcio, metodos para su preparacion y tratamiento de las enfermedades vasculares y diabetescon los mismos. | |
| PA8603001A1 (es) | Compuestos utiles para el tratamiento de enfermedades | |
| HN2001000223A (es) | Derivados de acido propionico | |
| AR058053A1 (es) | Formas cristalinas polimorficas de la sal de di- sodio del acido n- (5 -clorosaliciloil)-8- aminocaprilico | |
| AR032553A1 (es) | Derivados de alfa-amino-n-hidroxi-acetamida. | |
| HN2003000015A (es) | Sales estables del acido o acetilsalicilico con aminoacidos basicos i i. | |
| BRPI0417304A (pt) | composição, uso e processo para produção da mesma | |
| DOP2005000250A (es) | Amidas de acido pirazindicarboxilico y su uso |